Accordingly, the overexpression of RRM2 promotes the development of lung cancer in mice (Xu et al., 2008), and elevated levels of RRM2 are often linked to poor prognosis in different cancer types (Morikawa et al., 2010a, b; Jones et al., 2011). The gene discussed is RRM2; the disease is lung cancer.